Mraz Amerine & Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
RA
Mraz Amerine & Associates's CLB Position: Q3 2024 in Review
Mraz Amerine & Associates sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 62,205 shares — an estimated $1.26M sold.
Mraz Amerine & Associates first reported a position in CLB in Q4 2013 and held it in 18 quarters. The position peaked at $2.13M in Q1 2022. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.
- Mraz Amerine & Associates reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
- Mraz Amerine & Associates sold 62,205 Core Laboratories shares in Q3 2024, an estimated $1.26M.
- Mraz Amerine & Associates first reported a position in Core Laboratories in Q4 2013 and held it in 18 quarters.
- Mraz Amerine & Associates's Core Laboratories position peaked at $2.13M in Q1 2022.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.
Based on Mraz Amerine & Associates's 13F filing for Q3 2024, filed 23 Oct 2024.